Abstract Natural Language Processing (NLP) is a key technique for developing Medical Artificial Intelligence (AI) systems that leverage Electronic Health Record (EHR) data to build diagnostic and prognostic models. NLP enables the conversion of unstructured clinical text into structured data that can be fed into AI algorithms. The emergence of transformer architecture and large language models (LLMs) has led to advances in NLP for various healthcare tasks, such as entity recognition, relation extraction, sentence similarity, text summarization, and question-answering. In this article, we review the major technical innovations that underpin modern NLP models and present state-of-the-art NLP applications that employ LLMs in radiation oncology research. However, it is crucial to recognize that LLMs are prone to hallucinations, biases, and ethical violations, which necessitate rigorous evaluation and validation prior to clinical deployment. As such, we propose a comprehensive framework for assessing the NLP models based on their purpose and clinical fit, technical performance, bias and trust, legal and ethical implications, and quality assurance prior to implementation in clinical radiation oncology. Our article aims to provide guidance and insights for researchers and clinicians who are interested in developing and using NLP models in clinical radiation oncology. Natural Language Processing (NLP) is a key technique for developing Medical Artificial Intelligence (AI) systems that leverage Electronic Health Record (EHR) data to build diagnostic and prognostic models. NLP enables the conversion of unstructured clinical text into structured data that can be fed into AI algorithms. The emergence of transformer architecture and large language models (LLMs) has led to advances in NLP for various healthcare tasks, such as entity recognition, relation extraction, sentence similarity, text summarization, and question-answering. In this article, we review the major technical innovations that underpin modern NLP models and present state-of-the-art NLP applications that employ LLMs in radiation oncology research. However, it is crucial to recognize that LLMs are prone to hallucinations, biases, and ethical violations, which necessitate rigorous evaluation and validation prior to clinical deployment. As such, we propose a comprehensive framework for assessing the NLP models based on their purpose and clinical fit, technical performance, bias and trust, legal and ethical implications, and quality assurance prior to implementation in clinical radiation oncology. Our article aims to provide guidance and insights for researchers and clinicians who are interested in developing and using NLP models in clinical radiation oncology.
Mohammadi et al. (Wed,) studied this question.